Richard R. DeLuca - May 4, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP&Pres, Merck Animal Heallth
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Stock symbol
MRK
Transactions as of
May 4, 2024
Transactions value $
$1,755,303
Form type
4
Date filed
5/6/2024, 04:08 PM
Previous filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $3.46M +27.1K +19.86% $127.51 164K May 4, 2024 Direct
transaction MRK Common Stock Tax liability -$1.7M -13.4K -8.16% $127.51 150K May 4, 2024 Direct F1
holding MRK Common Stock - 401(k) Plan 1.24K May 4, 2024 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -27.1K -100% $0.00* 0 May 4, 2024 Common Stock 27.1K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4 These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.